Advanced Research in Metabolic Syndrome
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Endocrinology and Metabolism Research".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 23542
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue of Biomedicines focuses on advanced research in metabolic syndrome, regardless of whether it is pre-clinical, drug development research on laboratory animals or clinical research carried out with bioactive agents. As metabolic syndrome is highly diverse, affecting many organs (heart, brain, blood vessels, kidney, retina, etc.), and the intertwined diseases of the syndrome such as obesity, diabetes, dyslipidemia, and hypertension pose major challenges themselves, advanced therapeutic approaches developed against the syndrome can be of great benefit. Even less obviously related diseases—such as metabolic syndrome-related dementia types, endocrine function disorders, or microbiome changes—may also be of interest to the readership. Investigations of the prevention and treatment of macro- and microcirculatory damage associated with the different aforementioned diseases of metabolic syndrome are most welcome, but studies on other well-recognized pathways related to the syndrome such as oxidative stress, inflammation, and necro-apopto-autophagy are also welcome.
Dr. Balazs Varga
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- obesity
- diabetes
- dyslipidemia
- hypertension
- microcirculatory damage
- ischemia-reperfusion
- necro-apopto-autophagy
- laboratory animals
- bioactive agents
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.